← back to search

Honghui Zhou

Chinese PLA General Hospital · CN
Area of research
Radiology, Nuclear Medicine and Imaging · Immunology
Research interest
Research interests include Medicine, Pharmacokinetics, Ulcerative colitis, Golimumab, Daratumumab, and Infliximab.
h-index
citations
645
works
7
NIH funding
primary concept
email

Recent publications

Psychosocial functioning and its influencing factors in patients with depression post-remission: Implications for assessment and interventions
Journal of Affective Disorders 2024cited by 3position: middledoi
The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies
CPT Pharmacometrics & Systems Pharmacology 2023cited by 7position: middledoi
Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Golimumab in Children With Moderately to Severely Active Ulcerative Colitis
The Journal of Clinical Pharmacology 2018cited by 39position: lastdoi
Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies
Journal of Crohn s and Colitis 2016cited by 114position: middledoi
Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment
Clinical Pharmacokinetics 2016cited by 82position: middledoi
Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma
Clinical Pharmacology & Therapeutics 2016cited by 67position: middledoi
Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
Gastroenterology 2014cited by 333position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Omoniyi J. Adedokun · Johnson & Johnson (United States)3 papers (2014–2018)William J. Sandborn · Mirati Therapeutics (United States)2 papers (2014–2016)Xiaoyu Yan · South China Agricultural University2 papers (2016–2016)Brian G. Feagan · Western University2 papers (2014–2016)Colleen Marano · Johnson & Johnson (United States)2 papers (2014–2016) · 2 papers (2016–2016)Thomas A. Puchalski · CSL (United States)2 papers (2016–2016)Hugh M. Davis · Indiana University School of Medicine2 papers (2014–2016)Tahamtan Ahmadi · Genmab (United States)2 papers (2016–2016) · 2 papers (2016–2016)Zhenhua Xu · Hebei Medical University2 papers (2014–2016)Paul Rutgeerts · KU Leuven2 papers (2014–2016) · 2 papers (2014–2016)Richard Strauß · Janssen (United States)2 papers (2016–2018)Sagar Lonial · Emory University2 papers (2016–2016) · 1 papers (2016–2016)Daphne Chan · Johnson & Johnson (United States)1 papers (2018–2018)Juan José Pérez Ruixo · Amgen (United States)1 papers (2016–2016) · 1 papers (2018–2018)Hao Yang · Anhui Medical University1 papers (2024–2024)